by Plus Therapeutics | Jun 13, 2024 | Uncategorized
We are excited to have Greg Fuller, M.D., Ph.D., former Professor of Pathology (Neuro-Pathology) & Neuro-Radiology at The University of Texas MD Anderson Cancer Center join us as Vice President of Medical Affairs and Medical Director. Dr. Fuller will help lead the...
by Plus Therapeutics | Jun 10, 2024 | Uncategorized
Reminder to come by Plus Therapeutics at the SNMMI 2024 Annual Meeting in Toronto at Booth #1948 Learn about the latest ReSPECT-LM Clinical Trial data for Leptomeningeal Metastases and view our newest poster in the poster hall Two accepted abstracts titled:...
by Plus Therapeutics | May 31, 2024 | Uncategorized
📣 NEW GLIOBLASTOMA PODCAST EPISODE! Link to listen: https://bit.ly/4dZjfUD Thank you to @glioblastomaakagbm by @glioblastomaresearchorg for hosting our very own Dr. Marc Hedrick, President and CEO of Plus Therapeutics in your latest episode. Dr. Hedrick brings his...
by Plus Therapeutics | May 30, 2024 | Uncategorized
In honor of #BrainTumorAwarenessMonth, we would like to reshare some great educational, support and financial resources for patients and caregivers fighting a brain tumor diagnosis. More information can be found on our website at ReSPECT-Trials.com along with...
by Plus Therapeutics | May 28, 2024 | Uncategorized
#ICYMI: Replay the #Glioblastoma Patient Webinar from last week, hosted by Dr. Al Musella. The presentation included information about the ReSPECT-GBM clinical trial’s promising targeted radiotherapeutic working to treat Recurrent Glioblastoma and included a...
by Plus Therapeutics | May 20, 2024 | Uncategorized
🌟 Happy National Clinical Trials Day! 🌟 Today, we honor the incredible advancements made possible through clinical trials. These pivotal studies bring hope by paving the way for groundbreaking treatments and cures. At Plus Therapeutics, we are proud to be at the...
Recent Comments